SweetValueLab
Write for us

Moderna, Inc. — Financial Statements & Ratios

MRNA
NASDAQHealthcareBiotechnologyCIK 0001682852modernatx.comAbout MRNA
Last close · Oct 16, 2026218.01−18.49 (−7.82%)
Market cap$87.0B

Key indicators

Revenue2.2BTTM−27.6% on a year earlier+46.4% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
135.1M 60.2M−55.4%803.4M+1234.3%18.5B+2199.1%19.3B+4.3%6.8B−64.4%3.2B−52.7%1.9B−39.9%2.2B−27.6%2.1B 2.4B 3.4B
— -55.4% 1234.3% 2199.1% 4.3% -64.4% -52.7% -39.9% -27.6% 8.1% 15.7% 40.8%
— -$1.55 -$1.96−26.5%$28.29+1543.4%$20.12−28.9%-$12.33−161.3%-$9.28+24.7%-$7.26+21.8%-$7.98−6.3%-$8.31 -$4.74 -$2.72
Profitability
-306.0% -906.4%−600.4 pt-95.0%+811.4 pt72.0%+167.0 pt48.9%−23.1 pt-61.9%−110.8 pt-121.9%−60.0 pt-158.1%−36.2 pt-149.0%−42.7 pt· · ·
-284.8% -853.7%−568.9 pt-93.0%+760.7 pt66.1%+159.0 pt43.4%−22.7 pt-68.8%−112.2 pt-110.0%−41.2 pt-145.2%−35.1 pt-141.4%−47.1 pt· · ·
-25.1% -43.8%−18.6 pt-29.2%+14.6 pt86.3%+115.4 pt43.7%−42.5 pt-34.0%−77.8 pt-32.7%+1.4 pt-32.6%+0.0 pt— · · ·
Cash
-436.6M -490.5M−12.3%2.0B+499.5%13.3B+580.6%4.6B−65.6%-3.8B−183.5%-4.1B−6.0%-2.1B+49.1%-1.2B+64.4%· · ·
-323.3% -814.7%−491.4 pt243.9%+1058.6 pt72.2%−171.7 pt23.8%−48.4 pt-55.9%−79.6 pt-125.3%−69.5 pt-106.2%+19.1 pt-55.8%+57.6 pt· · ·
Balance sheet
— — — — — — — 0.07x 0.09x · · ·
— 331.00M 381.00M+15.1%431.00M+13.1%416.00M−3.5%382.00M−8.2%384.00M+0.5%389.00M+1.3%398.00M+2.6%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.